rewirebio.iobenchmarks
Configuration

AlphaGenome Splice-Junctions (Alavi 2026 v2)

AlphaGenome scored with the splice-junctions output and a grid-searched threshold, as configured in Alavi 2026 version 2.

3 evaluations · 14 results

Overview

AlphaGenome: AlphaGenome predicts regulatory activity and variant effects from long DNA sequences, with outputs for expression, splicing, chromatin and contact maps.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

3 evaluations · 14 results. Different protocols are not a single leaderboard.

Sorted by Accuracy (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetAccuracyFalse positive rate (type I error: false positives as a share of the benign set)PrecisionProportion (type II error: false negatives as a share of the splicing set (false-negative rate))RecallSpecificityProportion (share of 306 further OPA1 pathogenic substitutions called splice-altering)Proportion (share of 69 OPA1 VUS substitutions called splice-altering)
AlphaGenome Splice-Junctions (Alavi 2026 v2)EvaluationSpliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV), Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)96.2% (best in column)1 (0.9%) (best in column)98.6% (best in column)6 (7.9%)70 (92.1%)106 (99.1%) (best in column)Not reportedNot reported
AlphaGenome Splice-Junctions (Alavi 2026 v2)EvaluationSplice-defect classification of OPA1 variants with thresholds tuned on the same sets (Alavi Table III, evaluation sets), OPA1 LOVD evaluation sets (49 splicing, 79 benign)95.3%4 (5.1%)92.2%2 (4.1%) (best in column)47 (95.9%) (best in column)75 (94.9%)Not reportedNot reported
AlphaGenome Splice-Junctions (Alavi 2026 v2)EvaluationShare of further OPA1 pathogenic substitutions and VUS called splice-altering (Alavi Table III, extended corpus), OPA1 extended LOVD corpus (306 pathogenic substitutions, 69 VUS)Not reportedNot reportedNot reportedNot reportedNot reportedNot reported88 (28.8%)8 (11.6%)
All 14 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
96.2% Accuracy
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table IV, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Accuracy' (PDF page 9 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
98.6% Precision
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table IV, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'PPV' (PDF page 9 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
70 (92.1%) Recall
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table IV, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Sensitivity' (PDF page 9 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
106 (99.1%) Specificity
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table IV, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Specificity' (PDF page 9 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
1 (0.9%) False positive rate (type I error: false positives as a share of the benign set)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table IV, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Type I error' (PDF page 9 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Spliceogenic versus benign classification on an independent 65-gene set with OPA1-derived thresholds (Alavi Table IV)
Dataset: Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes)
6 (7.9%) Proportion (type II error: false negatives as a share of the splicing set (false-negative rate))
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on Multi-gene spliceogenic test set (76 spliceogenic, 107 benign, 65 genes) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-multigene

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table IV, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Type II error' (PDF page 9 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Splice-defect classification of OPA1 variants with thresholds tuned on the same sets (Alavi Table III, evaluation sets)
Dataset: OPA1 LOVD evaluation sets (49 splicing, 79 benign)
95.3% Accuracy
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on OPA1 LOVD evaluation sets (49 splicing, 79 benign) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-opa1-evaluation

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table III, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Accuracy' (PDF page 6 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Splice-defect classification of OPA1 variants with thresholds tuned on the same sets (Alavi Table III, evaluation sets)
Dataset: OPA1 LOVD evaluation sets (49 splicing, 79 benign)
92.2% Precision
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on OPA1 LOVD evaluation sets (49 splicing, 79 benign) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-opa1-evaluation

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table III, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'PPV' (PDF page 6 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Splice-defect classification of OPA1 variants with thresholds tuned on the same sets (Alavi Table III, evaluation sets)
Dataset: OPA1 LOVD evaluation sets (49 splicing, 79 benign)
47 (95.9%) Recall
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on OPA1 LOVD evaluation sets (49 splicing, 79 benign) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-opa1-evaluation

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table III, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Sensitivity' (PDF page 6 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Splice-defect classification of OPA1 variants with thresholds tuned on the same sets (Alavi Table III, evaluation sets)
Dataset: OPA1 LOVD evaluation sets (49 splicing, 79 benign)
75 (94.9%) Specificity
percent · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on OPA1 LOVD evaluation sets (49 splicing, 79 benign) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-opa1-evaluation

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table III, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Specificity' (PDF page 6 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Splice-defect classification of OPA1 variants with thresholds tuned on the same sets (Alavi Table III, evaluation sets)
Dataset: OPA1 LOVD evaluation sets (49 splicing, 79 benign)
4 (5.1%) False positive rate (type I error: false positives as a share of the benign set)
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on OPA1 LOVD evaluation sets (49 splicing, 79 benign) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-opa1-evaluation

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table III, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Type I error' (PDF page 6 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Splice-defect classification of OPA1 variants with thresholds tuned on the same sets (Alavi Table III, evaluation sets)
Dataset: OPA1 LOVD evaluation sets (49 splicing, 79 benign)
2 (4.1%) Proportion (type II error: false negatives as a share of the splicing set (false-negative rate))
percent · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on OPA1 LOVD evaluation sets (49 splicing, 79 benign) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-opa1-evaluation

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table III, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Type II error' (PDF page 6 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Share of further OPA1 pathogenic substitutions and VUS called splice-altering (Alavi Table III, extended corpus)
Dataset: OPA1 extended LOVD corpus (306 pathogenic substitutions, 69 VUS)
88 (28.8%) Proportion (share of 306 further OPA1 pathogenic substitutions called splice-altering)
percent · unknown

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on OPA1 extended LOVD corpus (306 pathogenic substitutions, 69 VUS) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-opa1-extended-positive-calls

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table III, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Positive mutations' (PDF page 6 of 12)
Configuration: AlphaGenome Splice-Junctions (Alavi 2026 v2)Protocol: Share of further OPA1 pathogenic substitutions and VUS called splice-altering (Alavi Table III, extended corpus)
Dataset: OPA1 extended LOVD corpus (306 pathogenic substitutions, 69 VUS)
8 (11.6%) Proportion (share of 69 OPA1 VUS substitutions called splice-altering)
percent · unknown

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

AlphaGenome Splice-Junctions on OPA1 extended LOVD corpus (306 pathogenic substitutions, 69 VUS) (Alavi 2026 v2)

rna-splicing-20261011-alavi2026-protocol-opa1-extended-positive-calls

Aggregation: Not reported

Probing Genomic Foundation Models with Splice-Variant Perturbations (Alavi, bioRxiv 2026, version 2) · Table III, row 'ALPHAGENOME SPLICE-JUNCTIONS', column 'Positive VUS' (PDF page 6 of 12)

Source checking is not independent reproduction. Release 2026-11-02-a7f03c9e55a5.

Use this configuration

How it works, versions and access

Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-02-a7f03c9e55a5
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-02-a7f03c9e55a5 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: rna-splicing-20261101-alavi2026-v2-config-alphagenome-splice-junctions

areas
dna-genomes
contexts
clinical_research
method types
supervised_machine_learning
reported name
ALPHAGENOME SPLICE-JUNCTIONS
foundation model eligible
false
version
Google Cloud API (research access), version not printed; scripts at https://github.com/marcel-2c8/splicing-model-eval-2026 commit 2a3875de
parameters
Custom predict_variant routine on the SPLICE_JUNCTIONS output over a 131,072-bp interval (±65,536 bp): per junction, the tissue track with the largest absolute log fold change ln(Alt + 1e-8) - ln(Ref + 1e-8); threshold >= 2.63
access reuse
Google DeepMind Research Access program API
source locator
Methods D 'AlphaGenome'; Tables III and IV row label
Related records

Suggest a correction